Loading insider details...
Latest Form 4 (Oct 21, 2026): Grant/Award of 310,000 IKT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 21, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 310,000 | n/a |
| Apr 20, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 100,000 | n/a |